Lumos Diagnostics Holdings Limited

ASX:LDX.AX

0.04 (AUD) • At close September 6, 2024
Bedrijfsnaam Lumos Diagnostics Holdings Limited
Symbool LDX.AX
Munteenheid AUD
Prijs 0.042
Beurswaarde 20,214,894
Dividendpercentage 0%
52-weken bereik 0.028 - 0.12
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. Douglas Ward
Website https://lumosdiagnostics.com

An error occurred while fetching data.

Over Lumos Diagnostics Holdings Limited

Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral

Vergelijkbare Aandelen

Althea Group Holdings Limited logo

Althea Group Holdings Limited

AGH.AX

0.02 AUD

Alterity Therapeutics Limited logo

Alterity Therapeutics Limited

ATH.AX

0.003 AUD

IDT Australia Limited logo

IDT Australia Limited

IDT.AX

0.115 AUD

Neurotech International Limited logo

Neurotech International Limited

NTI.AX

0.068 AUD

Resonance Health Limited logo

Resonance Health Limited

RHT.AX

0.062 AUD

Cryosite Limited logo

Cryosite Limited

CTE.AX

0.75 AUD

Compumedics Limited logo

Compumedics Limited

CMP.AX

0.32 AUD

Financiële Gegevens

Cijfers zijn in miljoenen (AUD)

Cijfers zijn in miljoenen (AUD)